NCT00184730

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Investigation of the Efficacy and Safety of hGH in Long Term (More Than 48 Weeks) in GHDA.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 86 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 19 Years – 67 Years
• Healthy volunteers: Not accepted

Summary

This trial is conducted in Japan. This protocol describes an extension trial to supply hGH to subjects who wish continuous treatment after the long-term Phase 3 trial (GHLiquid-1519) until hGH products have been approved for GHDA in Japan.

Conditions

• Growth Hormone Disorder
• Adult Growth Hormone Deficiency

Interventions

Type	Name	Description
DRUG	somatropin

Timeline

• Start date: 2004-11-01
• Primary completion: 2006-09-01
• Completion: 2006-09-01
• First posted: 2005-09-16
• Last updated: 2016-11-17

Locations

1 site across 1 country: Japan